XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases.
$1.96+0.51%
报价 2026-11-13
市值
$59.8M
EV
$-52.7M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -27.7%
$1.85$2.71
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| XBITXBiotech Inc. | $59.8M | +0.5% | – | 0% | – | – | – | |
| RLMDRelmada Therapeutics, Inc. | $449.1M | +1.2% | +300.0% | 0% | – | – | – | |
| NTRBNutriband Inc. | $74.1M | +2.2% | +3433.3% | 33.1% | – | – | – | |
| ADAGAdagene Inc. | $64.4M | -14.5% | – | 94.2% | – | – | – | |
| FBIOFortress Biotech, Inc. | $62.7M | -5.5% | +31.4% | 64.5% | 1.0x | – | 0.8x | |
| ACRVAcrivon Therapeutics, Inc. Common Stock | $62.1M | -0.7% | +1400.0% | 0% | – | – | – | |
| GANXGain Therapeutics, Inc. | $44.4M | -3.7% | – | 0% | – | – | – | |
| ACETAdicet Bio, Inc. | $26M | -5.1% | 0.0% | 0% | – | – | – | |
| CRVOCervoMed Inc. | $25.6M | -7.7% | -91.7% | 0% | – | – | – | |
| 同行中位数 | – | – | +165.7% | 0% | 1.0x | – | 0.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。